Discontinued — last reported Q3 '17
Deferred Tax Liabilities
Merck & Co. Deferred Tax Liabilities increased by 82.2% to $5.57B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 82.2%, from $3.06B to $5.57B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Liabilities shows an upward trend with a 15.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase indicates higher future tax obligations, while a decrease suggests the settlement or reversal of these temporary differences.
Detailed definition
Deferred tax liabilities represent the anticipated future tax payments resulting from temporary differences between the...
Peer comparison
Common in capital-intensive industries where accelerated depreciation for tax purposes creates significant timing differences.
deferred_tax_liabilitiesHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $4.75B | $4.30B | $2.84B | $3.06B | $5.57B |
| QoQ Change | — | -9.4% | -33.9% | +7.6% | +82.2% |
| YoY Change | — | -9.4% | -33.9% | +7.6% | +82.2% |
Deferred Tax Liabilities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s deferred tax liabilities?
- Merck & Co. (MRK) reported deferred tax liabilities of $5.57B in Q4 2025.
- How has Merck & Co.'s deferred tax liabilities changed year-over-year?
- Merck & Co.'s deferred tax liabilities increased by 82.2% year-over-year, from $3.06B to $5.57B.
- What is the long-term trend for Merck & Co.'s deferred tax liabilities?
- Over 5 years (2020 to 2025), Merck & Co.'s deferred tax liabilities has grown at a 15.8% compound annual growth rate (CAGR), from $2.68B to $5.57B.
- What does deferred tax liabilities mean?
- Future tax obligations resulting from timing differences between accounting and tax reporting.